CBIS News and Press, Cannabis Science Inc From 03/26/19

New Jersey lawmakers have canceled their planned vote on Monday, April 1, on legalizing the recreational use of marijuana for adults at least 21 years old. More news on: Cronos Group Inc., Canopy Growth Corporation, Tilray, Inc., Healthcare stocks news, Consumer stocks news, News on ETFs...

A new study documents a sharp rise in emergency room visits linked with marijuana use following legalization in Colorado, Business Insider reports. More news on: Canopy Growth Corporation, Tilray, Inc., Cronos Group Inc., Consumer stocks news, News on ETFs, Read more ...

Cannabis Science ( OTCPK:CBIS ) has expanded into the Canadian market with the formation of Cannabis Science Canada, Inc. More news on: Cannabis Science, Inc., Healthcare stocks news, Read more ...

IRVINE, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has expanded into the Canadian market with the formation of Cannabi...

IRVINE, CA, March 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that today it has launched the selection and appointment process for the Company’s iCan...

Cannabis Science ( OTCPK:CBIS ) intends to expand its sponsored research in Nigeria to include neurological conditions, including Post-Traumatic Stress Disorder (PTSD). More news on: Cannabis Science, Inc., Healthcare stocks news, Read more ...

IRVINE, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Pre-Clinical Work and Animal Studies Underway, and Protocols for Clinical Studies Under Development   via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-ba...

Researchers have found that cannabis use during the teenage years was associated with a nearly 40% bump in the risk of depression and a 50% increase in the risk of suicidal thoughts in adulthood, according to a study published in JAMA Psychiatry. More news on: Tilray, Inc., Cronos Group,...

IRVINE, CA, Feb. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it has received an incredible response from shareholders registering for RCD Personal Sharehold...

CORAL GABLES, FL / ACCESSWIRE / January 31, 2019 / The marijuana stock market has remained consistently in the spotlight this year. As we've seen over the past couple of months, several countries, including the United States, passed positive legislation in favor of the legalization of cann...